Chemical Compound
Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-
CAS Registry Number
162808-62-0
Primary record
Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-
- 库存
- 3,103 克
- 纯度
- 99.6 %
- CAS
- 162808-62-0
化合物标识与属性
- CAS
- 162808-62-0
- PubChem CID
- 16119814
- SMILES
- CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O
- Canonical SMILES
- CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O
名称与同义词
- Caspofungin
- caspofungine
- Caspofungina
- Cancidas
- caspofunginum
- Caspofungin acetate
- Caspofungin [INN]
- caspofungin diacetate
- 162808-62-0
- Caspofungin Impurity 17
- F0XDI6ZL63
- RefChem:56792
- Caspofungin [INN:BAN]
- CASPOFUNGIN [MI]
- CASPOFUNGIN [HSDB]
- UNII-F0XDI6ZL63
- (10R,12S)-caspofungin
- CASPOFUNGIN [VANDF]
- CASPOFUNGIN [WHO-DD]
- CASPOFUNGIN [EMA EPAR]
- orb1739130
- SCHEMBL7903583
- CHEMBL1630575
- HSDB 7476
- DTXSID30873204
- J02AX04
- CHEBI:474180
- DTXCID701508490
- GLXC-05478
- MK-0991
- EBC-27523
- HY-17006A
- MFCD30541213
- ACN-036877
- BAT-010107
- MK 0991
- DA-62083
- L-743872
- L-743,872
- 3117B
- CS-0009545
- FT-0696944
- J3.260.940F
- L 743872
- A978945
- EN300-22853765
- L743872
- L743,872
- L 743,872
- Q63413125
- N0001-011142
- Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-
- (4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide
- (10R,12S)-N-(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-(1R)-3-amino-1-hydroxypropyl-21-(2-aminoethyl)amino-6-(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl-11,20,25-trihydroxy-15-(1R)-1-hydroxyethyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo22.3.0.0,9,13heptacosan-18-yl-10,12-dimethyltetradecanamide
- (10R,12S)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0,9,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
- (10R,12S)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
- (4R,5S)-5-((2-aminoethyl)amino)-n2-(10,12-dimethyltetradecanoyl)-4-hydroxy-l-ornithyl-l-threonyl-trans-4-hydroxy-l-prolyl-(s)-4-hydroxy-4-(p-hydroxyphenyl)-l-threonyl-threo-3-hydroxy-l-ornithyl-trans-3-hydroxy-l-proline cyclic (1->6) disulfide
- Cyclo[L-Thr-4beta-hydroxy-L-Pro-[(4S)-4-hydroxy-4-(4-hydroxyphenyl)-L-Thr-]-[(3R)-3-hydroxy-L-Orn-]-3beta-hydroxy-L-Pro-[(4R,5S)-N2-(10,12-dimethyltetradecanoyl)-4-hydroxy-5-(2-aminoethylamino)-L-Orn*-]]
- Cyclo[L-Thr-4beta-hydroxy-L-Pro-[(4S)-4-hydroxy-4-(4-hydroxyphenyl)-L-Thr-]-[(3R)-3-hydroxy-L-Orn-]-3beta-hydroxy-L-Pro-[(4R,5S)-N2-[(10R,12S)-10,12-dimethyltetradecanoyl]-4-hydroxy-5-(2-aminoethylamino)-L-Orn*-]]
- Cyclo[L-Thr-L-t4Hyp-[(3S,4S)-3,4-dihydroxy-4-(4-hydroxyphenyl)-L-Abu-]-[(3R)-3-hydroxy-L-Orn-]-[(3S)-3-hydroxy-L-Pro-]-[(4R,5S)-5-[(2-aminoethyl)amino]-4-hydroxy-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-L-Orn*-]]
- N-((3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-((1R)-3-amino-1-hydroxypropyl)-21-((2-aminoethyl)amino)-6-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-11,20,25-trihydroxy-15-((1R)-1-hydroxyethyl)-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo(22.3.0.0^(9,13))heptacosan-18-yl)-10,12-dimethyltetradecanamide
- pneumocandin b0, 1-((4R,5S)-5-((2-aminoethyl)amino)-n2-((10R,12S)-10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-l-ornithine)-5-((3R)-3-hydroxy-l-ornithine)-
- Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-